Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
Completed · Phase 2
Conditions studied: Metastatic Cancer, Sarcoma
In brief
RATIONALE: Inhaling aerosolized sargramostim before and after surgery may interfere with the growth of tumor cells and shrink the tumor so that it can be removed during surgery. Sargramostim may then kill any tumor cells remaining after surgery. This may be an effective treatment for osteosarcoma that has spread to the lung. PURPOSE: This phase II trial is studying how well inhaled sargramostim works in treating patients who are undergoing surgery for the first recurrence of osteosarcoma that has spread to the lung.
Key facts
- Study ID
- NCT00066365
- Run by
- Children's Oncology Group
- People needed
- 49
- Starts
- 2004-07-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2015-03-30
Who can join
Age: any, up to 39. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Phoenix Children's Hospital — Phoenix, Arizona, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center — Tucson, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
- Southern California Permanente Medical Group — Downey, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center — Loma Linda, California, United States
- Jonathan Jaques Children's Cancer Center at Miller Children's Hospital — Long Beach, California, United States
- Children's Hospital and Research Center Oakland — Oakland, California, United States
- University of California Davis Cancer Center — Sacramento, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States
- Stanford Cancer Center — Stanford, California, United States
- Alfred I. duPont Hospital for Children — Wilmington, Delaware, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center — Washington D.C., District of Columbia, United States
- Children's National Medical Center — Washington D.C., District of Columbia, United States
- Lee Cancer Care of Lee Memorial Health System — Fort Myers, Florida, United States
- University of Florida Shands Cancer Center — Gainesville, Florida, United States
- Nemours Children's Clinic — Jacksonville, Florida, United States
- University of Miami Sylvester Comprehensive Cancer Center - Miami — Miami, Florida, United States
- Miami Children's Hospital — Miami, Florida, United States
- Baptist-South Miami Regional Cancer Program — Miami, Florida, United States
- Nemours Children's Clinic - Orlando — Orlando, Florida, United States
- Sacred Heart Cancer Center at Sacred Heart Hospital — Pensacola, Florida, United States
- All Children's Hospital — St. Petersburg, Florida, United States
- St. Joseph's Cancer Institute at St. Joseph's Hospital — Tampa, Florida, United States
- Kaplan Cancer Center at St. Mary's Medical Center — West Palm Beach, Florida, United States
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.